» Articles » PMID: 26503331

Whole Exome Sequencing Identifies Frequent Somatic Mutations in Cell-Cell Adhesion Genes in Chinese Patients with Lung Squamous Cell Carcinoma

Abstract

Lung squamous cell carcinoma (SQCC) accounts for about 30% of all lung cancer cases. Understanding of mutational landscape for this subtype of lung cancer in Chinese patients is currently limited. We performed whole exome sequencing in samples from 100 patients with lung SQCCs to search for somatic mutations and the subsequent target capture sequencing in another 98 samples for validation. We identified 20 significantly mutated genes, including TP53, CDH10, NFE2L2 and PTEN. Pathways with frequently mutated genes included those of cell-cell adhesion/Wnt/Hippo in 76%, oxidative stress response in 21%, and phosphatidylinositol-3-OH kinase in 36% of the tested tumor samples. Mutations of Chromatin regulatory factor genes were identified at a lower frequency. In functional assays, we observed that knockdown of CDH10 promoted cell proliferation, soft-agar colony formation, cell migration and cell invasion, and overexpression of CDH10 inhibited cell proliferation. This mutational landscape of lung SQCC in Chinese patients improves our current understanding of lung carcinogenesis, early diagnosis and personalized therapy.

Citing Articles

MCPIP1 modulates the miRNA‒mRNA landscape in keratinocyte carcinomas.

Lichawska-Cieslar A, Szukala W, Ylla G, Machaj G, Ploskonka F, Chlebicka I J Exp Clin Cancer Res. 2024; 43(1):290.

PMID: 39428471 PMC: 11492624. DOI: 10.1186/s13046-024-03211-8.


Genomic Landscape of Pulmonary Sarcomatoid Carcinoma.

Kwon H, Lee S, Han Y, Lee J, Kwon S, Kim H Cancer Res Treat. 2023; 56(2):442-454.

PMID: 37973906 PMC: 11016656. DOI: 10.4143/crt.2023.764.


Characterization of Immune-Related Molecular Subtypes and a Prognostic Signature Correlating With the Response to Immunotherapy in Patients With Gastric Cancer.

Wang G, Yang L, Wang Y, Hu R, Zhang K, Guo T Front Immunol. 2022; 13:939836.

PMID: 35898512 PMC: 9309259. DOI: 10.3389/fimmu.2022.939836.


In silico mutational analysis of ACE2 to check the susceptibility of lung cancer patients towards COVID-19.

Khalid Z, Khan A, Alnajjar R, Santali E, Shakoori A Sci Rep. 2022; 12(1):7798.

PMID: 35552474 PMC: 9098448. DOI: 10.1038/s41598-022-11805-5.


Identification and verification of the molecular mechanisms and prognostic values of the cadherin gene family in gastric cancer.

Luo S, Lin R, Liao X, Li D, Qin Y Sci Rep. 2021; 11(1):23674.

PMID: 34880371 PMC: 8655011. DOI: 10.1038/s41598-021-03086-1.


References
1.
Solis L, Behrens C, Dong W, Suraokar M, Ozburn N, Moran C . Nrf2 and Keap1 abnormalities in non-small cell lung carcinoma and association with clinicopathologic features. Clin Cancer Res. 2010; 16(14):3743-53. PMC: 2920733. DOI: 10.1158/1078-0432.CCR-09-3352. View

2.
Maemondo M, Inoue A, Kobayashi K, Sugawara S, Oizumi S, Isobe H . Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR. N Engl J Med. 2010; 362(25):2380-8. DOI: 10.1056/NEJMoa0909530. View

3.
Fujita T, Kiyama M, Tomizawa Y, Kohno T, Yokota J . Comprehensive analysis of p53 gene mutation characteristics in lung carcinoma with special reference to histological subtypes. Int J Oncol. 1999; 15(5):927-34. DOI: 10.3892/ijo.15.5.927. View

4.
Sasaki H, Hikosaka Y, Okuda K, Kawano O, Moriyama S, Yano M . NFE2L2 gene mutation in male Japanese squamous cell carcinoma of the lung. J Thorac Oncol. 2010; 5(6):786-9. DOI: 10.1097/JTO.0b013e3181db3dd3. View

5.
Taguchi K, Motohashi H, Yamamoto M . Molecular mechanisms of the Keap1–Nrf2 pathway in stress response and cancer evolution. Genes Cells. 2011; 16(2):123-40. DOI: 10.1111/j.1365-2443.2010.01473.x. View